NEW YORK, Jan. 12, 2015 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Roka Bioscience, Inc. ("Roka" or the "Company") (NASDAQ: ROKA), concerning whether the board has breached its fiduciary duties to shareholders.
Roka only recently went public in during the summer of 2014. In the Company's offering documents, it stated that its business prospects were strong and installations of its main product, the Atlas instrument, were growing.
On November 6, 2014, the Company announced that installation Atlas instruments did not increase during the third quarter of 2014. Additionally, revenue for the quarter also did not increase.
Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.
If you own Roka shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
Email: [email protected]
Follow us on Twitter: @HarwoodFeffer
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.
The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
SOURCE Harwood Feffer LLP